Vitalograph is a global leader in respiratory diagnostics, offering a broad portfolio of solutions for clinical practice, and clinical trials with respiratory and cough endpoints. Founded in the UK in 1963, Vitalograph gives healthcare providers the most comprehensive range of pulmonary function testing options available, supporting a more complete understanding of patient lung health. In 2024, Vitalograph acquired long-term collaborator Morgan Scientific, which is now its locally-based, US division focused on enabling respiratory diagnostic excellence, including sales, implementation, and support.